Log In
BCIQ
Print this Print this
 

Ameluz, aminolevulinic acid (BF-200 ALA)

  Manage Alerts
Collapse Summary General Information
Company Biofrontera AG
DescriptionPhotodynamic therapy (PDT) comprising nanoemulsion BF-200 with 5-aminolevulinic acid photosensitizer followed by red light illumination using the BF-RhodoLED lamp or daylight
Molecular Target Not available
Mechanism of ActionPhotodynamic therapy
Therapeutic ModalityMedical Devices: Photodynamic therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$1.6M

0


 Deals Details
Get a free BioCentury trial today